Skip to main content

Drug Safety

      Autoinflammatory/Still's Disease Panel - EULAR2020

      Drs. Olga Petryna, Petros Efthimiou, Apostolos Kontzias and Jack Cush discuss autoinflammatory highlights from the Virtual EULAR 2020 meeting June 3-6

      SELECT-Choice: UPA vs ABA in RA

      Dr. Jack Cush from EULAR2020 Virtual Conference

      OP0151

      Updated EULAR Recommendations for RA Management

      Dr. Kathryn Dao from EULAR2020 Virtual Conference

      GCA and Risk of Cancer or Visual Loss

      Dr. Olga Petryna from EULAR2020 Virtual Conference

      OP0149 Tocilizumab Treats Visual Loss in GCA

      OP0143 GCA in Israel and risk of Cancer

      Bimekizumab in Ankylosing Spondylitis

      Dr. Rachel Tate from EULAR2020 Virtual Conference

      Enticing New Options in ANCA-Associated Vasculitis

      Dr. David Liew from EULAR2020 ANCA-Associated Vasculitis Avacopan vs Prednisone MAINRITSAN 2 study - Calprotectin

      Lupus Management at EULAR 2020

      Dr. Kathryn Dao highlights SLE presentations from virtual EULAR 2020 meeting June 3-6, 2020

      - HCQ levels predicts VTE

      - Can you withdraw MMF in stable SLE patients?

      -Updated EULAR Lupus Treatment guidelines

      ×